Low-cost fixes like reflective paint and shade could save lives from extreme heat

NCT ID NCT06983483

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether affordable home improvements (like reflective roof paint and better airflow) plus community education can reduce heat-related illness and improve quality of life in rural Pakistan. Over 7,000 people in 11 villages will be tracked for two years. Some homes will get cooling upgrades and heat safety advice, while others will not, so researchers can compare the effects.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Community education and awareness (behavioral intervention) plus home cooling modifications (shade, reflective roof paint, airflow improvements)
What this could lead to
If successful, this could provide affordable, scalable strategies to protect vulnerable communities from extreme heat and reduce heat-related health problems.
What could go wrong
This is a large but early-stage trial in a specific rural setting, so results may not apply to other regions. The interventions are low-cost and low-risk, but their real-world impact on health outcomes is still uncertain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEAT ILLNESS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Heat Stress Disorders

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Aga Khan University Hospital

    RECRUITING

    Matiari, Pakistan

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.